Compositions and methods of use for treatment of mammalian diseases

Abstract

This disclosure relates to a Composition having medicinal properties for use with mammalian diseases such as anti-cancer properties and methods of use, anti-viral properties and methods of use, anti-protozoan properties and methods of use, and anti-bacterial properties and methods of use in mammals. The chemical Composition is used as a pharmaceutical of a biologically acceptable copper compound and may include other components such as iron, which is transported to afflicted cells in a pharmaceutical acceptable carrier.

What is claimed is: 
     
         1 . A method for use in treating cancer, cell proliferating diseases, solid tumors, liquid tumors, myelodysplasia disorders, hyper proliferative disorders, plasma cell dyscrasias and metastatic diseases in a patient comprising: a core of at least a biologically acceptable fixed copper compound, and a sheath, a shell, a polymeric shell, a cover, a casing, an encoating, a jacket or combination thereof that encapsulates the biologically acceptable copper compound, said sheath, shell, polymeric shell, cover, casing, encoating, jacket or combination thereof being made of a material targeting cancer cells, cell proliferating disease cells, solid tumor cells, liquid tumor cells, myelodysplasia cells, hyper proliferative disorder cells, plasma cell dyscrasias cells or metastatic disease cells, and preventing immediate chemical interaction of the core with the surrounding environment and a pharmaceutically acceptable carrier. 
     
     
         2 . The method of  claim 1 , wherein the sheath is formed of a material selected from the group consisting essentially of a glucose, a saccharide, a polysaccharide, a dextran, liposomes, derivatives and combinations thereof. 
     
     
         3 . The method of  claim 1 , wherein the sheath is formed of a material selected from the group consisting essentially of lipids, polypeptides, oligopeptides, polynucleotides, proteins, and combinations thereof. 
     
     
         4 . The method of  claim 2  or  3 , wherein a liposome coat encapsulates the sheath. 
     
     
         5 . The method of  claim 1  wherein said fixed copper compound is selected from the group consisting of cupric hydroxide, copper oxide, copper oxychloride, cupric carbonate basic, copper sulfate, copper sulfate basic, cuprous oxide, cupric hydroxide-iron hydroxide, copper-iron oxide, cupric citrate, cupric glycinate, cupric gluconate, cupric phosphate, cuprobam, cupric salicylite, indigo copper, cupro-cupric sulfate, cuprous sulfate, cuprous sulfate hemihydrite, any of the natural copper containing minerals such as cupric sulfate basic, the minerals brochantite, langite, malachite, azurite, cheesylite, cornetite, dihydyrite, libethenite, phosphorochalcite, pseudolibethenite, pseudo-malachite, tagilite, antierite, covellite, marshite, cuprite, chalcocite Rogojski's salt, brochantite, hydrocyanite, chalcanthtite, nantokite or dolerophane. 
     
     
         6 . A method for treating virus, bacteria and protozoa-infected cells and viral, bacterial, cancers, cell proliferating diseases and protozoal diseases in a patient comprising: forming a colloidal solution composition of at least a fixed copper compound core, a sheath and a pharmaceutically acceptable carrier; administering the colloidal solution composition to a patient; monitoring the presence of viruses in the patient; and re-administering the composition at intervals based on results of the monitoring; further comprising administering a redistribution agent after the administration of the composition; prior to the administration of the composition; co-administration with the composition and combinations thereof.